| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $235.1M | +7.4% |
| Cost of Revenue | $77.4M | +9.9% |
| Gross Profit | $157.7M | +6.2% |
| R&D Expense | $38.4M | -7.9% |
| SG&A Expense | $58.3M | +4.9% |
| Operating Income | -$28.9M | -6.5% |
| Pre-tax Income | -$27.3M | -133.6% |
| Income Tax | $2.5M | -9.3% |
| Net Income | -$29.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.5M | -56.0% |
| Accounts Receivable | $64.4M | -1.1% |
| Inventory | $15.6M | +29.0% |
| Current Assets | $146.3M | -25.9% |
| Total Assets | $289.2M | -13.7% |
| Current Liabilities | $114.8M | +3.6% |
| Total Liabilities | $130.1M | -1.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | -85.5% |
| Capital Expenditures | $12.5M | +149.9% |
| Investing Cash Flow | -$12.0M | -125.8% |
| Financing Cash Flow | -$32.1M | -339.2% |
| Free Cash Flow | -$23.2M | -115.3% |
| -106.5% |
| EPS (Basic) | -$0.74 | -105.6% |
| EPS (Diluted) | -$0.74 | -105.6% |
| Stockholders' Equity |
| $159.1M |
| -21.7% |